Pfizer CEO Albert Bourla on Sunday said the vaccine maker plans to submit data on a fourth dose of its COVID-19 vaccine to the U.S. Food and Drug Administration because protection after three doses is “not that good against infections” and “doesn’t last very long” when faced with a variant like Omicron.
As the Russian invasion of Ukraine moves past its third week, there are slight hopes that negotiations between the two sides may soon produce a ceasefire. But with the shrill warmongering talk in Washington, it almost seems like the US government would hate to see that happen.